Blog

ISCO Develops Technology to Replace Cartilage for the Treatment of Osteoarthritis

CARLSBAD, CA–(Marketwired – September 30, 2015) – International Stem Cell Corporation (OTCQB: ISCO)(www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company developing novel stem cell-based therapies, today announced that the Company’s scientific team has developed a robust innovative technology to generate functional articular cartilage from the patient’s own skin or adipose tissue to treat osteoarthritis. […]

Read More >>